Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001477932-14-007353
Filing Date
2014-12-29
Accepted
2014-12-29 15:51:46
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-KT citius_10kt.htm 10-KT 631529
2 EMPLOYMENT AGREEMENT citius_ex104.htm EX-10.4 75001
3 SUBSIDIARIES citius_ex21.htm EX-21 1420
4 CERTIFICATION citius_ex311.htm EX-31.1 8943
5 CERTIFICATION citius_ex321.htm EX-32.1 3590
  Complete submission text file 0001477932-14-007353.txt   3158532

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT citius-20140930.xml EX-101.INS 309303
7 XBRL TAXONOMY EXTENSION SCHEMA citius-20140930.xsd EX-101.SCH 35623
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE citius-20140930_cal.xml EX-101.CAL 39858
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE citius-20140930_def.xml EX-101.DEF 65515
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE citius-20140930_lab.xml EX-101.LAB 201457
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE citius-20140930_pre.xml EX-101.PRE 150515
Mailing Address 63 GREAT ROAD MAYNARD MA 01754
Business Address 63 GREAT ROAD MAYNARD MA 01754 (978) 938-0338
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-KT | Act: 34 | File No.: 333-170781 | Film No.: 141312637
SIC: 3714 Motor Vehicle Parts & Accessories